Understanding how incretin hormones affect insulin secretion in diabetes
Mechanisms Driving the Kinetics of Incretin-Mediated Beta Cell Responses
This study is looking at how certain hormones in your body help your pancreas release insulin, which is important for managing Type 2 Diabetes, and it aims to find better ways to treat the condition by understanding how these hormones work.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-11034049 on NIH RePORTER |
What this research studies
This research investigates the roles of incretin hormones, specifically GLP-1 and GIP, in stimulating insulin secretion from beta cells in individuals with Type 2 Diabetes Mellitus (T2DM). By examining how these hormones activate specific receptors and generate cAMP, a crucial signaling molecule, the study aims to uncover the differences in their effectiveness. The research employs advanced imaging techniques to visualize cAMP responses in beta cells, providing insights into the mechanisms that may lead to improved diabetes treatments. Ultimately, this work seeks to bridge knowledge gaps regarding incretin signaling and its impact on insulin secretion.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Type 2 Diabetes Mellitus who are interested in new treatment options.
Not a fit: Patients with Type 1 Diabetes or those without diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for Type 2 Diabetes Mellitus by enhancing our understanding of incretin hormone signaling.
How similar studies have performed: Previous research has shown promising results in understanding incretin signaling, but this specific comparison of GLP-1 and GIP signaling kinetics is novel.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Chan, Michelle Ying-Ying — University of California at Davis
- Study coordinator: Chan, Michelle Ying-Ying
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.